Molecular Devices Corp.
This article was originally published in The Gray Sheet
Executive Summary
Secondary offering of $150 mil. in common stock is outlined in a filing with the Securities and Exchange Commission, including shares to be offered by the company and selling shareholders. Underwriters for the offering include ING Barings, Bear Stearns, Thomas Weisel Partners and Warburg Dillon Read. The Sunnyvale, California firm launched two high throughput microplate readers for use in drug discovery and life science research March 6, including the Spectramax Gemini XS fluorescence microplate reader and Plus384 absorbance microplate reader